β-Catenin links von Hippel-Lindau to Aurora kinase A and loss of primary cilia in renal cell carcinoma

Journal of the American Society of Nephrology

Volumn 26, Issue 3, 2015, Pages 553-564

  Dere, Ruhee ^a   Perkins, Ashley Lyn ^a   Bawa Khalfe, Tasneem ^b   Jonasch, Darius ^a   Walker, Cheryl Lyn ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; BETA CATENIN; HISTONE DEACETYLASE 6; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; TRANSCRIPTION FACTOR 7; VON HIPPEL LINDAU PROTEIN; AURKA PROTEIN, HUMAN; CTNNB1 PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN;

ARTICLE; CELL FRACTIONATION; CELL LOSS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME REPRESSION; EUKARYOTIC FLAGELLUM; GENE SILENCING; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; NULL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; EPITHELIUM CELL; KIDNEY TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

AURORA KINASE A; BETA CATENIN; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CILIA; EPITHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY NEOPLASMS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84924061350     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013090984     Document Type: Article

References (55)

1. Bausch B, Jilg C, Gläsker S, Vortmeyer A, Lützen N, Anton A, Eng C, Neumann HP: Renal cancer in von Hippel-Lindau disease and related syndromes. Nat Rev Nephrol 9: 529-538, 2013
2. Valladares Ayerbes M, Aparicio Gallego G, Díaz Prado S, Jiménez Fonseca P, García Campelo R, Antón Aparicio LM: Origin of renal cell carcinomas. Clin Transl Oncol 10: 697-712, 2008
3. Stebbins CE, Kaelin WG Jr, Pavletich NP: Structure of the VHL-ElonginCElonginB complex: Implications for VHL tumor suppressor function. Science 284: 455-461, 1999
4. Haase VH: Renal cancer: Oxygen meets metabolism. Exp Cell Res 318: 1057-1067, 2012
5. Li L, Kaelin WG Jr: New insights into the biology of renal cell carcinoma. Hematol Oncol Clin North Am 25: 667-686, 2011
6. Thoma CR, Matov A, Gutbrodt KL, Hoerner CR, Smole Z, Krek W, Danuser G: Quantitative image analysis identifies pVHL as a key regulator of microtubule dynamic instability. J Cell Biol 190: 991-1003, 2010
7. Thoma CR, Toso A, Gutbrodt KL, Reggi SP, Frew IJ, Schraml P, Hergovich A, Moch H, Meraldi P, Krek W: VHL loss causes spindle misorientation and chromosome instability. Nat Cell Biol 11: 994-1001, 2009
8. Pan J, Seeger-Nukpezah T, Golemis EA: The role of the ciliumin normal and abnormal cell cycles: Emphasis on renal cystic pathologies. Cell Mol Life Sci 70: 1849-1874, 2013
9. Basten SG, Giles RH: Functional aspects of primary cilia in signaling, cell cycle and tumorigenesis. Cilia 2: 6, 2013
10. Kuehn EW, Walz G, Benzing T: von Hippel-Lindau: A tumor suppressor links microtubules to ciliogenesis and cancer development. Cancer Res 67: 4537-4540, 2007
11. Thoma CR, Frew IJ, Hoerner CR, Montani M, Moch H, Krek W: pVHL and GSK3beta are components of a primary cilium-maintenance signalling network. Nat Cell Biol 9: 588-595, 2007
12. Basten SG, Willekers S, Vermaat JS, Slaats GG, Voest EE, van Diest PJ, Giles RH: Reduced cilia frequencies in human renal cell carcinomas versus neighboring parenchymal tissue. Cilia 2: 2, 2013
13. Frew IJ, Thoma CR, Georgiev S, Minola A, Hitz M, Montani M, Moch H, Krek W: pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation. EMBO J 27: 1747-1757, 2008
14. Montani M, Heinimann K, von Teichman A, Rudolph T, Perren A, Moch H: VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: Further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease. Am J Surg Pathol 34: 806-815, 2010
15. Ezratty EJ, Stokes N, Chai S, Shah AS, Williams SE, Fuchs E: A role for the primary cilium in Notch signaling and epidermal differentiation during skin development. Cell 145: 1129-1141, 2011
16. Habbig S, Bartram MP, Müller RU, Schwarz R, Andriopoulos N, Chen S, Sägmüller JG, Hoehne M, Burst V, Liebau MC, Reinhardt HC, Benzing T, Schermer B: NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway. J Cell Biol 193: 633-642, 2011
17. Schneider L, Clement CA, Teilmann SC, Pazour GJ, Hoffmann EK, Satir P, Christensen ST: PDGFRalphaalpha signaling is regulated through the primary cilium in fibroblasts. Curr Biol 15: 1861-1866, 2005
18. Simons M, Gloy J, Ganner A, Bullerkotte A, Bashkurov M, Krönig C, Schermer B, Benzing T, Cabello OA, Jenny A, Mlodzik M, Polok B, Driever W, Obara T, Walz G: Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat Genet 37: 537-543, 2005
19. Waters AM, Beales PL: Ciliopathies: An expanding disease spectrum. Pediatr Nephrol 26: 1039-1056, 2011
20. Pugacheva EN, Jablonski SA, Hartman TR, Henske EP, Golemis EA: HEF1-dependent Aurora A activation induces disassembly of the primary cilium. Cell 129: 1351-1363, 2007
21. Ferchichi I, Kourda N, Sassi S, Romdhane KB, Balatgi S, Cremet JY, Prigent C, Elgaaied AB: Aurora A overexpression and pVHL reduced expression are correlated with a bad kidney cancer prognosis. Dis Markers 33: 333-340, 2012
22. Ricketts C, Zeegers MP, Lubinski J, Maher ER: Analysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in familial and sporadic renal cell carcinoma. PLoS ONE 4: e6037, 2009
23. Martin B, Chesnel F, Delcros JG, Jouan F, Couturier A, Dugay F, LeGoff X, Patard JJ, Fergelot P, Vigneau C, Rioux-Leclerq N, Arlot-Bonnemains Y: Identification of pVHL as a novel substrate for Aurora-A in clear cell renal cell carcinoma (ccRCC). PLoS ONE 8: e67071, 2013
24. Xu J, Li H, Wang B, Xu Y, Yang J, Zhang X, Harten SK, Shukla D, Maxwell PH, Pei D, Esteban MA: VHL inactivation induces HEF1 and Aurora kinase A. J Am Soc Nephrol 21: 2041-2046, 2010
25. Zhou MI, Wang H, Foy RL, Ross JJ, Cohen HT: Tumor suppressor von Hippel-Lindau (VHL) stabilization of Jade-1 protein occurs through plant homeodomains and is VHL mutation dependent. Cancer Res 64: 1278-1286, 2004
26. Zhou MI, Wang H, Ross JJ, Kuzmin I, Xu C, Cohen HT: The von Hippel-Lindau tumor suppressor stabilizes novel plant homeodomain protein Jade-1. J Biol Chem 277: 39887-39898, 2002
27. Chitalia VC, Foy RL, Bachschmid MM, Zeng L, Panchenko MV, Zhou MI, Bharti A, Seldin DC, Lecker SH, Dominguez I, Cohen HT: Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL. Nat Cell Biol 10: 1208-1216, 2008
28. Lian X, Duan X, Wu X, Li C, Chen S, Wang S, Cai Y, Weng Z: Expression and clinical signifi cance of von Hippel-Lindau downstream genes: Jade-1 and beta-catenin related to renal cell carcinoma. Urology 80: 485.e7-485.e13, 2012
29. Shinojima T, Oya M, Takayanagi A, Mizuno R, Shimizu N, Murai M: Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha. Carcinogenesis 28: 529-536, 2007
30. Kaidi A, Williams AC, Paraskeva C: Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 9: 210-217, 2007
31. Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, Lee E: The way Wnt works: Components and mechanism. Growth Factors 31: 1-31, 2013
32. Dutta-Simmons J, Zhang Y, Gorgun G, Gatt M, Mani M, Hideshima T, Takada K, Carlson NE, Carrasco DE, Tai YT, Raje N, Letai AG, Anderson KC, Carrasco DR: Aurora kinase A is a target of Wnt/beta-catenin involved in multiple myeloma disease progression. Blood 114: 2699-2708, 2009
33. Xu C, Kim NG, Gumbiner BM: Regulation of protein stability by GSK3 mediated phosphorylation. Cell Cycle 8: 4032-4039, 2009
34. Dar AA, Belkhiri A, El-Rifai W: The aurora kinase A regulates GSK-3beta in gastric cancer cells. Oncogene 28: 866-875, 2009
35. Gonsalves FC, Klein K, Carson BB, Katz S, Ekas LA, Evans S, Nagourney R, Cardozo T, Brown AM, DasGupta R: An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway. Proc Natl Acad Sci U S A 108: 5954-5963, 2011
36. Narayanan BA, Doudican NA, Park J, Xu D, Narayanan NK, Dasgupta R, Mazumder A: Antagonistic effect of small-molecule inhibitors of Wnt/β-catenin in multiple myeloma. Anticancer Res 32: 4697-4707, 2012
37. Kurahashi T, Miyake H, Hara I, Fujisawa M: Signifi cance of Aurora-A expression in renal cell carcinoma. Urol Oncol 25: 128-133, 2007
38. Li Y, Zhou W, Wei L, Jin J, Tang K, Li C, Teh BT, Chen X: The effect of Aurora kinases on cell proliferation, cell cycle regulation and metastasis in renal cell carcinoma. Int J Oncol 41: 2139-149, 2012
39. Maruschke M, Hakenberg OW, Koczan D, Zimmermann W, Stief CG, Buchner A: Expression pro fi ling of metastatic renal cell carcinoma using gene set enrichment analysis. Int J Urol 21: 46-51, 2014
40. Klein A, Flügel D, Kietzmann T: Transcriptional regulation of serine/threonine kinase-15 (STK15) expression by hypoxia and HIF-1. Mol Biol Cell 19: 3667-3675, 2008
41. Cui SY, Huang JY, Chen YT, Song HZ, Huang GC, De W, Wang R, Chen LB: The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma. Cell Cycle 12: 2849-2866, 2013
42. Fanale D, Bazan V, Corsini LR, Caruso S, Insalaco L, Castiglia M, Cicero G, Bronte G, Russo A: HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions. Breast Cancer Res Treat 140: 505-517, 2013
43. Ku JH, Park YH, Myung JK, Moon KC, Kwak C, Kim HH: Expression of hypoxia inducible factor-1α and 2α in conventional renal cell carcinoma with or without sarcomatoid differentiation. Urol Oncol 29: 731-737, 2011
44. Park YK, Park B, Lee S, Choi K, Moon Y, Park H: Hypoxia-inducible factor-2α-dependent hypoxic induction of Wnt10b expression in adipogenic cells. J Biol Chem 288: 26311-26322, 2013
45. Choi H, Chun YS, Kim TY, Park JW: HIF-2alpha enhances beta-catenin/TCF-driven transcription by interacting with beta-catenin. Cancer Res 70: 10101-10111, 2010
46. Criscimanna A, Duan LJ, Rhodes JA, Fendrich V, Wickline E, Hartman DJ, Monga SP, Lotze MT, Gittes GK, Fong GH, Esni F: PanIN-specific regulation of Wnt signaling by HIF2α during early pancreatic tumorigenesis. Cancer Res 73: 4781-4790, 2013
47. Gordan JD, Lal P, Dondeti VR, Letrero R, Parekh KN, Oquendo CE, Greenberg RA, Flaherty KT, Rathmell WK, Keith B, Simon MC, Nathanson KL: HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell 14: 435-446, 2008
48. Kim SH, Xia D, Kim SW, Holla V, Menter DG, Dubois RN: Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells. Cancer Res 70: 4054-4063, 2010
49. Li Y, Bavarva JH, Wang Z, Guo J, Qian C, Thibodeau SN, Golemis EA, Liu W: HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression. Oncogene 30: 2633-2643, 2011
50. Xia Z, Wei P, Zhang H, Ding Z, Yang L, Huang Z, Zhang N: AURKA maintains self-renewal in glioma-initiating cells through the stabilization of beta-catenin and activation ofWnt signaling. Mol Cancer Res 11: 1101-1111, 2013
51. Voronkov A, Krauss S: Wnt/beta-catenin signaling and small molecule inhibitors. Curr Pharm Des 19: 634-664, 2013
52. Lancaster MA, Louie CM, Silhavy JL, Sintasath L, Decambre M, Nigam SK, Willert K, Gleeson JG: Impaired Wnt-beta-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy. Nat Med 15: 1046-1054, 2009
53. Wheway G, Abdelhamed Z, Natarajan S, Toomes C, Inglehearn C, Johnson CA: Aberrant Wnt signalling and cellular over-proliferation in a novel mouse model of Meckel-Gruber syndrome. Dev Biol 377: 55-66, 2013
54. Abdelhamed ZA, Wheway G, Szymanska K, Natarajan S, Toomes C, Inglehearn C, Johnson CA: Variable expressivity of ciliopathy neurological phenotypes that encompass Meckel-Gruber syndrome and Joubert syndrome is caused by complex de-regulated ciliogenesis, Shh and Wnt signalling defects. Hum Mol Genet 22: 1358-1372, 2013
55. Borgal L, Habbig S, Hatzold J, Liebau MC, Dafinger C, Sacarea I, Hammerschmidt M, Benzing T, Schermer B: The ciliary protein nephrocystin-4 translocates the canonical Wnt regulator Jade-1 to the nucleus to negatively regulate β-catenin signaling. J Biol Chem 287: 25370-25380, 2012